Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice.

Abstract

Dipeptidyl peptidase 4 (DPP-4) inhibitors are current drugs for the treatment of type 2 diabetes (T2D) based on their main property to enhance endogenous glucagon-like peptide-1 (GLP-1) levels, thus increasing insulin secretion. However, the mechanism of action of DPP-4 inhibition in extra pancreatic tissues has been poorly investigated and it might occur… (More)
DOI: 10.1016/j.regpep.2014.05.001

Topics

Cite this paper

@article{Darsalia2014LinagliptinEN, title={Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice.}, author={Vladimer Darsalia and Anna Olverling and Martin Larsson and Shiva Mansouri and David Nathanson and Thomas Nystr{\"{o}m and T. Borsoi Klein and {\AA}ke Sj{\"{o}holm and Cesare Patrone}, journal={Regulatory peptides}, year={2014}, volume={190-191}, pages={25-31} }